Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Non-cash Items (2016 - 2018)

Tandem Diabetes Care filings provide 6 years of Non-cash Items readings, the most recent being $117.0 million for Q4 2018.

  • On a quarterly basis, Non-cash Items rose 19312.39% to $117.0 million in Q4 2018 year-over-year; TTM through Dec 2018 was $117.0 million, a 19312.39% increase, with the full-year FY2018 number at $117.0 million, up 19312.39% from a year prior.
  • Non-cash Items hit $117.0 million in Q4 2018 for Tandem Diabetes Care, up from $602646.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $117.0 million in Q4 2018 to a low of $602646.0 in Q4 2017.
  • Median Non-cash Items over the past 5 years was $19.2 million (2015), compared with a mean of $32.4 million.
  • Biggest five-year swings in Non-cash Items: plummeted 91.68% in 2016 and later soared 19312.39% in 2018.
  • Tandem Diabetes Care's Non-cash Items stood at $23.5 million in 2014, then decreased by 18.59% to $19.2 million in 2015, then plummeted by 91.68% to $1.6 million in 2016, then crashed by 62.17% to $602646.0 in 2017, then soared by 19312.39% to $117.0 million in 2018.
  • The last three reported values for Non-cash Items were $117.0 million (Q4 2018), $602646.0 (Q4 2017), and $1.6 million (Q4 2016) per Business Quant data.